RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY)

niversity Of Oxford0 个研究点目标入组 480 人开始时间: 2023年10月9日最近更新: 2024年8月21日

适应症

试验速览

暂无简介。

•Hospitalised patients aged =18 years, Pneumonia syndrome (clinical diagnosis, in general based on a) typical symptoms of new respiratory infection, b) objective evidence of acute lung disease [e.g. hypoxia or compatible imaging or clinical examination], and c) alternative causes considered unlikely, One of the following diagnoses: a) Confirmed influenza A or B infection b) Community-acquired pneumonia with planned antibiotic treatment (without suspected or confirmed SARS-CoV-2, influenza, active pulmonary tuberculosis, or Pneumocystis pneumonia), No medical history that might, in the opinion of the patient’s doctor, put the patient at significant risk if he/she were to participate in the trial, No reason that the trial treatment definitely should, or should not, be given in the opinion of the patient’s doctor (this only affects eligibility for the relevant comparison)

发起方